<DOC>
	<DOCNO>NCT02610491</DOCNO>
	<brief_summary>Metabolic Syndrome ( MS ) well-known group obesity-related metabolic disorder include insulin resistance ( IR ) , dyslipidemia hypertension ( HTN ) . In addition , overweight causal relationship chronic low grade systemic inflammatory condition increase intestinal permeability . Over last decade , multiplex disorder progressively become major worldwide public health problem , association increase risk type 2 diabetes mellitus ( DM2 ) , atherosclerotic cardiovascular disease all-cause mortality . Scientific evidence measure improve cardiometabolic intestinal health non-pharmaceutical mean urgent need . Administration flavonoid hesperidin risk may beneficial effect glucose / insulin metabolism , lipid metabolism , blood pressure , heart rate , pro-inflammatory oxidative stress biomarkers gut barrier function . Objective : To determine 12-week effect daily administration hesperidin main cardiometabolic disorder related MS assess investigation glucose/insulin metabolism , blood lipid profile , blood pressure , heart rate , body composition gut barrier function subject risk MS. Study design : This randomize , double-blind , placebo-controlled study parallel design . Study population : Healthy ( male/female ) volunteer , age 18-65 , risk metabolic syndrome ( present 2 5 component NCEP-ATP-III criterion ) . Intervention : Participants randomly assign one intervention group . One group receive one daily dose hesperidin capsule group receive identical look placebo capsule period 12 week . The capsule ingest glass water every morning breakfast . Main study parameters/endpoints : The primary efficacy parameter study oral glucose tolerance test ( OGTT ) , validated surrogate endpoint study β-cell function insulin sensitivity . Secondary endpoint entail evaluation effect daily administration hesperidin lipid profile ( blood measurement ) , blood pressure heart rate , body composition , low-grade inflammation biomarkers ( blood measurement ) gut barrier function ( blood measurement , fecal sample , urine collection ) .</brief_summary>
	<brief_title>The Effect Hesperidin Glucose / Insulin Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>* Subjects risk metabolic syndrome : combination 2 5 component : Waist circumference : men &gt; 102 cm / woman &gt; 88 cm Triglycerides : ≥ 1.7 mmol/l HDLcholesterol : men ≤ 1.0 mmol/l / woman ≤ 1.3 mmol/l Systolic blood pressure : ≥ 130 mmHg diastolic blood pressure : ≥ 85 mmHg Fasted serum glucose ≥ 6.1 mmol/L Type 2 diabetes mellitus ( define fast plasma glucose ≥7.0 mmol/l ) Gastroenterological diseases abdominal surgery Cardiovascular disease , cancer , liver kidney malfunction , thyroid disorder , disease life expectancy short 5 year Selfadmitted HIVpositive status Abuse product ; alcohol ( &gt; 20 alcoholic consumption per week ) drug Smoking Plans lose weight follow hypocaloric diet study period Weight gain loss &gt; 3 kg previous 3 month Use medication interfere endpoint Use antioxidant , mineral vitamin supplement available pharmacy , drugstore , food market alternative medicine Hormone replacement therapy ( woman ) . Use antibiotic 90 day prior start study Administration investigational drug participation scientific intervention study may interfere study ( decided principle investigator ) 180 day prior study Known pregnancy ( assessed pregnancy test start study ) lactation Blood donation within 3 month study period Failure comply prohibit intake hesperidin contain food product study period . A list forbidden product provide participant History side effect towards intake flavonoid citrus fruit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>